Distinct risk profiles of early and advanced atherosclerosis: Prospective results from the Bruneck study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 529-537

  Willeit, Johann ^a   Kiechl, Stefan ^b   Oberhollenzer, Friedrich ^b   Rungger, Gregor ^b   Egger, Georg ^b   Bonora, Enzo ^b   Mitterer, Manfred ^b   Muggeo, Michele ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b NONE

Author keywords

Atherogenesis; Carotid arteries; Epidemiology; Risk factors; Ultrasonics

Indexed keywords

ALBUMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; FERRITIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTHROMBIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FIBRINOLYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHYROIDISM; IRON STORAGE; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

EID: 0033979623     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.529     Document Type: Article

References (50)

1. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, Bommer W, Price TR, Gardin JM, Savage PJ, the CHS Collaborative Research Group. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992; 23:1752-1760.
2. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb. 1991;11:966-972.
3. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279:119-124.
4. Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation. 1998;97:1467-1473.
5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
6. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis: a multifactorial disease. Circulation. 1993;87(suppl II):II-3-II-16.
7. Kiechl S, Willeit J. The natural course of atherosclerosis, I: incidence and progression. Arterioscler Thromb Vasc Biol. 1999;19:1484-1490.
8. Kiechl S, Willeit J. The natural course of atherosclerosis, II: vascular remodeling. Arterioscler Thromb Vasc Biol. 1999;19:1491-1498.
9. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis: a population-based study. Arterioscler Thromb. 1993;13:661-668.
10. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation. 1997;96:3300-3307.
11. Kiechl S, Willeit J, Rungger G, Egger G, Oberhollenzer F, Bonora E. Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study. Stroke. 1998;29:900-907.
12. Kiechl S, Muigg A, Santer P, Mitterer M, Egger G, Oberhollenzer M, Oberhollenzer F, Mayr A, Gasperi A, Poewe W, Willeit J. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation. 1999;99:614-619.
13. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993;341:255-259.
14. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Lipoprotein(a) and asymptomatic carotid artery disease: evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Stroke. 1995;26:1582-1587.
15. Kiechl S, Willeit J. Low sensitivity to APC not caused by the factor V Leiden mutation. Circulation. In press.
16. World Health Organisation. Arterial Hypertension: Report of a WHO Study Group. Geneva, Switzerland: WHO: 1978:9-17 (Technical Report Series No. 628).
17. WHO Study Group on Diabetes Mellitus. Technical Report Series No. 727. Geneva, Switzerland: World Health Organisation; 1985.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
19. Clauss A. Gerinnungsphysiologische Schnellinethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
20. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1988.
21. Wilcosky TC, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis. 1985; 38:849-856.
22. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med. 1976;295:369-377, 420-425.
23. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
24. Von Rokitansky C. A Manual of Pathological Anatomy. Berlin, Germany: Sydenham Society; 1852;4:261.
25. Duguid JB, Robertson WB. Mechanical factors in atherosclerosis. Lancet. 1957;1:1205-1209.
26. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
27. Salonen R, Salonen JT. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Med. 1991;23:23-27.
28. Gura T. Infections: a cause of artery-clogging plaques? Science. 1998; 281:35,37.
29. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-4103.
30. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
31. Witteman JC, Grobbee DE, Valkenhurg HA, van Hemert AM, Stijnen T, Hofman A. Cigarette smoking and the development and progression of aortic atherosclerosis: a 9-year population-based follow-up study in women. Circulation. 1993;88:2156-2162.
32. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997; 17:2167-2176.
33. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med. 1989;320:915-924.
34. Salonen JT, Korpela H, Nyyssonen K, Porkkala E, Tuomainen TP, Belcher JD, Jacobs DR Jr, Salonen R. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med. 1995;237: 161-168.
35. Araujo JA, Romano EL, Brito BE, Parthe V, Romano M, Bracho M, Montano RF, Cardier J. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol. 1995; 15:1172-1180.
36. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86: 803-811.
37. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993;341:454-457.
38. Nedrebo BG, Ericsson UB, Nygard O, Refsum H, Ueland PM, Aakvaag A, Aanderud S, Lien EA. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism. 1998;47:89-93.
39. Barth JD, Jansen H, Kromhout D, Reiber JH, Birkenhager JC, Arntzenius AC. Progression and regression of human coronary atherosclerosis: the role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Atherosclerosis. 1987;68:51-58.
40. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci. 1995;88:629-633.
41. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in non-diabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1997;28:1710-1716.
42. Folsom AR, Wu KK, Shahar E, Davis CE the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb. 1993;13:1829-1836.
43. De Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis. 1996;121:185-191.
44. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
45. McGill HC. Smoking and the pathogenesis of atherosclerosis. Adv Exp Med Biol. 1990;273:9-16.
46. Schneider DJ, Nordt TK, Sobel BE. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes. 1993;42:1-7.
47. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature. 1989;339: 301-303.
48. Terres W, Tatsis E, Pfalzer B, Beil U, Beisiegel U, Hamm CW. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 1995;91:948-950.
49. 2) synthesis, platelet aggregation, and platelet thromboxane release. BMJ. 1983;287: 1495-1498.
50. Becker RC. Thrombosis and the role of the platelet. Am J Cardiol. 1999;83:3E-6E.